Clinical Trials Browser

Neuroblastoma, Ganglioneuroblastoma

Brain Neoplasms

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell

Nasopharyngeal Carcinoma

Squamous Cell Carcinoma of Head and Neck

Prostatic Neoplasms

Burkitt Lymphoma, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Biphenotypic, Acute

Rhabdomyosarcoma, Embryonal

Medulloblastoma

Pancreatic Neoplasms

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Nasopharyngeal Carcinoma

Squamous Cell Carcinoma of Head and Neck

Thyroid Neoplasms

Prostatic Neoplasms

Pelvic Neoplasms

Breast Neoplasms

Diffuse Intrinsic Pontine Glioma

Oligodendroglioma

Oligodendroglioma

Squamous Cell Carcinoma of Head and Neck

Esophageal Neoplasms

Nasopharyngeal Carcinoma, Pathologic Complete Response

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Lymphoma, Lymphoma, Follicular, Neoplasm, Residual

Carcinoma, Hepatocellular

Prostatic Neoplasms

Anus Neoplasms

Carcinoma, Hepatocellular

Breast Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Locally Advanced Rectal Cancer (LARC)

Radiation Injuries, Disease Progression

Rectal Adenocarcinoma with Mismatch-repair Deficient (dMMR)/ Microsatellite Instability-high (MSI-H)

Genital Diseases, Male, Prostatic Diseases

Castration-resistant Prostate Cancer

Neoplasm Metastasis, Prostatic Neoplasms

Uterine Cervical Neoplasms

Oropharyngeal Neoplasms

Nasopharyngeal Carcinoma

Uterine Cervical Neoplasms

Stomach Neoplasms

Rectal Neoplasms

Astrocytoma, Oligodendroglioma

Clinical Trials

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases

JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

HOPE

Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma

A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

LAP100

Postoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3)

Postoperative Radiotherapy Combined With Nimotuzumab Followed by Benmelstobart in High-Risk Patients With Head and Neck Squamous Cell Carcinoma

STABLE-MATES

ANDROMEDA

Reduced-dose vs Standard-dose Irradiation for Low-risk Clinical Target Volume in Nasopharyngeal Carcinoma.

RePaIr-HN

Adjuvant Radiotherapy in High Risk Locally Advanced DTC

REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial

BEFORE

OLIGAMI

BIOMEDE 2

ImproveCodel

POLO

Sintilimab Plus Chemotherapy as Neoadjuvant and Adjuvant Treatment for Locally Advanced Oral Squamous Cell Carcinoma

Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer

Reduced-dose Versus Conventional-dose Intensity-modulated Radiation Therapy for Locally Advanced Nasopharyngeal Carcinoma With Remission After Induction Chemotherapy and Immunotherapy

Head and Neck Cancer Study Project in the Geriatric Population

FIL_GAZEBO

Adjuvant Radiotherapy of Sintilimab Versus TACE for HCC

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

KANALRAD

Continuation of First-line Therapy With Radiotherapy Versus Early Switch to Second-line Therapy in Oligoprogressive HCC

PRATO

GrandP/SPCG19

PEACE 7

Personalized Long-course Radiotherapy Plus Chemotherapy With or Without Immunotherapy for LARC: PALACE Study

Omitting CTV for Primary Tumor in LS-SCLC

PREDIR-NEOREC

Standard of Care +/- 177Lu-PSMA-617 In de Novo mHSPC Patients With Poor PSA Response (PEACE6-Poor Responders)

MEDCARE

SPARKLE

ONCOCOL01

SwallPEG

Radiotherapy Alone Versus Concurrent Chemo-radiotherapy for Nasopharyngeal Carcincoma Patients With Undectable EBV DNA After One Cylce Neoadjuvant Chemotherpy

Adjuvant Concurrent Chemoradiotherapy Versus Radiotherapy in Early-stage Cervical Cancer Patients

Study of Adjuvant Chemotherapy With or Without PD-1 Inhibitors and Chemoradiotherapy in Resected pN3 Gastric (G) or GEJ Adenocarcinoma

JCOG1801

Efficacy of Post-radiation Adjuvant Temozolomide Chemotherapy in Residue Low-grade Glioma